Table: Hisamitsu - 9-MTH group results

Hisamitsu Pharmaceutical Co

12/01/2023 06:00

Jan 12 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2022        Nov 30, 2021     Feb 28, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               91.88               86.66           123.00    
                   (+6.0 pct)          (+7.2 pct)       (+2.3 pct)  
  Operating            8.51                6.97            11.10    
                   (+22.0 pct)         (-14.2 pct)      (+18.9 pct) 
  Recurring           13.00                8.67            12.70    
                   (+50.1 pct)         (+9.3 pct)       (+0.5 pct)  
  Net                  9.52                6.22             9.70    
                   (+53.1 pct)         (+8.7 pct)       (+0.4 pct)  
  EPS              119.46 yen           76.14 yen       121.68 yen  
  EPS Diluted      119.36 yen           76.09 yen                   
  Ann Div                               84.00 yen        84.50 yen  
  -Q2 div           42.25 yen           42.00 yen                   
  -Q4 div                               42.00 yen        42.25 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T